In support of this, a direct relationship between the co-expression of HIF-1α and the CD44+/CD24−/low phenotype has been observed by immunohistochemical analyses of 253 samples of breast ductal carcinoma from patients, and associated with a worse prognosis of breast cancer patients [50]. This evidence concerns the gene HIF1A and breast cancer.